Package 0615-8511-39

Brand: pentoxifylline

Generic: pentoxifylline
NDC Package

Package Facts

Identity

Package NDC 0615-8511-39
Digits Only 0615851139
Product NDC 0615-8511
Product ID 0615-8511_e3966eca-d995-479b-b2a3-4fd6eea51cb1
Description

30 TABLET, EXTENDED RELEASE in 1 BLISTER PACK (0615-8511-39)

Marketing

Marketing Status
Marketed Since 2024-06-26
Brand pentoxifylline
Generic pentoxifylline
Sample Package No

Linked Drug Pages (1)

Pentoxifylline ndc-match (0.95)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "e3966eca-d995-479b-b2a3-4fd6eea51cb1", "openfda": {"nui": ["N0000175895", "N0000009065"], "unii": ["SD6QCT3TSU"], "rxcui": ["312301"], "spl_set_id": ["bd2f2672-62cd-4e77-8b0b-782f5d06198b"], "pharm_class_pe": ["Hematologic Activity Alteration [PE]"], "pharm_class_epc": ["Blood Viscosity Reducer [EPC]"], "manufacturer_name": ["NCS HealthCare of KY, LLC dba Vangard Labs"]}, "finished": true, "packaging": [{"sample": false, "description": "30 TABLET, EXTENDED RELEASE in 1 BLISTER PACK (0615-8511-39)", "package_ndc": "0615-8511-39", "marketing_start_date": "20240626"}], "brand_name": "Pentoxifylline", "product_id": "0615-8511_e3966eca-d995-479b-b2a3-4fd6eea51cb1", "dosage_form": "TABLET, EXTENDED RELEASE", "pharm_class": ["Blood Viscosity Reducer [EPC]", "Hematologic Activity Alteration [PE]"], "product_ndc": "0615-8511", "generic_name": "Pentoxifylline", "labeler_name": "NCS HealthCare of KY, LLC dba Vangard Labs", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Pentoxifylline", "active_ingredients": [{"name": "PENTOXIFYLLINE", "strength": "400 mg/1"}], "application_number": "ANDA074878", "marketing_category": "ANDA", "marketing_start_date": "20240115", "listing_expiration_date": "20261231"}